Full text
=========

Many years mortality in ARDS, often complicating CCT, is still very high and reaches 70-80%. In ARDS patients, hypoxia is a result of a \`vicious circle\' when acute respiratory insufficiency intensifies acute cardiac insufficiency which, in turn, deepens respiratory failure.

Patients and methods
--------------------

The study is based on the data obtained from 45 patients with moderate-severe CCT. During conventional treatment in ICU, after 48--72 h, in 21 patients (48%) an ARDS developed, and three of these patients were treated with HBOT in a mono-placed barochamber. All treatments were conducted under 1.6--2.0 ata for 40-60 min each every day during 4--15 days, depending on progress of the recovery. Monitoring of cardiac function was carried out using non-invasive impedance cardiography (IC). Stroke Volume Index (SVI) and Cardiac Output Index (COI) were calculated. Respiratory functions were checked using a gas-analyzer. All ARDS patients were divided into three groups: group A-4 surviving patients after conventional therapy; group B-14 deceased patients after conventional therapy, and group C-3 patients surviving after addition of HBOT.

Results
-------

Obtained data was exposed to statistical analysis using Student\'s unpaired t-test and the results are presented in Table [1](#T1){ref-type="table"}.

Conclusions
-----------

This study clearly shows that: 1) in ARDS patients after CCT the state of cardiac function is the factor determining development of respiratory hypoxia; 2) HBOT is a decisive treatment improving cardio-respiratory function which leads to the favorable outcome; 3) patients with CCT must be treated with HBOT just after the trauma, before ARDS has developed.

  Groups   PaO~2~ (mmHg) -mean   SVI (ml m^-2^) - mean   COI (I min^-1^m^-2^) - mean   HR(b min^-1^) - mean                                                                  
  -------- --------------------- ----------------------- ----------------------------- ---------------------- ---------- ---------- ------ ---------- ------ ----- --------- ----------
  A        49.7                  57.9                    78\. 0^\*\*\#\#^              31.9                   46.4       50.0^\#^   3.77   4.76       4.34   108   101^\#^   90^\#^
  B        61.8                  52.3                    40.0^\*\*^                    33.6                   38.2       27.3       3.14   4.66^\*^   3.42   98    132^\*^   116
  C        55.8                  60.1                    87.3^\*\*\#\#^                33.7                   48.4^\*^   49.4^\#^   3.55   5.25^\*^   5.09   103   105^\#^   86^\*\#^
  Phases   I                     II                      III                           I                      II         III        I      II         III    I     II        III

The differences between the means was considered significant if *P*\<0.05 (^\*^ or ^\#^), *P*\<0.01 (^\*\*^ or ^\#\#^). ^\*^ - vs phase I; ^\*\*^ - vs phases I and II; ^\#^ or ^\#\#^ - vs group B.
